Stocktoria
Edwards Lifesciences Corp EW
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2000-03-27
Edwards Lifesciences Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.1B | $5.4B | $5.0B | $4.5B | $5.2B |
| Gross profit | $4.7B | $4.3B | $4.0B | $3.7B | $4.0B |
| R&D expense | $1.1B | $1.1B | $962.9M | $843.6M | $903.1M |
| SG&A expense | $2.1B | $1.8B | $1.6B | $1.4B | $1.5B |
| Operating income | $1.3B | $1.4B | $1.3B | $1.5B | $1.7B |
| Interest expense | — | — | $17.6M | $19.2M | $18.4M |
| Income tax | $216.9M | $152.1M | $152.4M | $195.5M | $198.9M |
| Net income | $1.1B | $4.2B | $1.4B | $1.5B | $1.5B |
| EPS (diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
| Operating cash flow | $1.6B | $542.3M | $895.8M | $1.2B | $1.7B |
| Free cash flow | $1.3B | $289.9M | $642.8M | $973.6M | $1.4B |
| Cash & equivalents | $2.9B | $3.0B | $1.1B | $769.0M | $862.8M |
| Inventory | $1.1B | $1.1B | $903.5M | $875.5M | $726.7M |
| Total assets | $13.7B | $13.1B | $9.4B | $8.3B | $8.5B |
| Total liabilities | $3.4B | $3.0B | $2.6B | $2.5B | $2.7B |
| Shareholders' equity | $10.3B | $10.1B | $6.7B | $5.8B | $5.8B |
Source: SEC EDGAR filings · CIK 0001099800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.